This is a unique opportunity to join Orion Pharma's Innovative Medicines business division as it expands its global footprint from Europe to the Americas and Asia. We are seeking a high-caliber Business Development leader to lead strategic sourcing, evaluation, and execution of external innovation opportunities in oncology, with a primary focus on in-licensing, partnerships, and acquisition transactions. This role is responsible for identifying high-value assets and technologies aligned with the company's therapeutic priorities, driving end-to-end deal execution, and shaping long-term portfolio strategy through external innovation.
Lead identification, evaluation, and prioritization of in-licensing and acquisition opportunities across priority therapeutic areas, with a strong emphasis on scientific and commercial fit
Drive end-to-end transaction execution, including deal structuring, valuation, negotiation, and internal governance approvals
Partner closely with R&D, clinical, regulatory, commercial, and finance teams to assess opportunities, define target product profiles, and build robust business cases
Maintain deep external network across biotech, venture capital, academia, and industry to proactively source differentiated opportunities
Lead cross-functional due diligence teams, synthesizing scientific, clinical, regulatory, and commercial insights into clear investment recommendations
Develop and execute partnering strategies aligned with corporate and therapeutic area strategies
Monitor competitive landscape, emerging science, and deal trends to inform proactive business development efforts
This role reports to Vice President, Business Development & Partnerships, Innovative Medicines. This position is based in Cambridge, MA, US.
What you can expect from us
At Orion, your work creates true impact and well-being for our customers, patients and society at large. Our culture of friendliness, respe